Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$4.78 - $15.01 $1.19 Million - $3.75 Million
249,781 New
249,781 $1.32 Million
Q3 2022

Nov 14, 2022

SELL
$10.22 - $23.7 $415,524 - $963,594
-40,658 Reduced 15.23%
226,240 $2.61 Million
Q2 2022

Aug 15, 2022

BUY
$4.35 - $15.85 $222,319 - $810,061
51,108 Added 23.68%
266,898 $3.02 Million
Q1 2022

May 11, 2022

BUY
$4.55 - $6.41 $28,032 - $39,492
6,161 Added 2.94%
215,790 $1.04 Million
Q4 2021

Feb 11, 2022

BUY
$5.89 - $9.73 $125,374 - $207,112
21,286 Added 11.3%
209,629 $1.24 Million
Q3 2021

Nov 12, 2021

BUY
$6.78 - $9.89 $173,174 - $252,610
25,542 Added 15.69%
188,343 $1.61 Million
Q2 2021

Aug 11, 2021

BUY
$7.24 - $11.2 $162,009 - $250,622
22,377 Added 15.94%
162,801 $1.31 Million
Q1 2021

May 13, 2021

SELL
$8.05 - $20.78 $47,430 - $122,435
-5,892 Reduced 4.03%
140,424 $1.51 Million
Q4 2020

Feb 09, 2021

BUY
$2.36 - $9.99 $31,121 - $131,738
13,187 Added 9.91%
146,316 $1.27 Million
Q3 2020

Nov 12, 2020

BUY
$2.58 - $3.36 $1,119 - $1,458
434 Added 0.33%
133,129 $348,000
Q2 2020

Aug 12, 2020

BUY
$3.01 - $4.02 $331,683 - $442,979
110,194 Added 489.73%
132,695 $443,000
Q1 2020

May 06, 2020

SELL
$2.58 - $4.58 $2,577 - $4,575
-999 Reduced 4.25%
22,501 $73,000
Q1 2019

May 14, 2019

SELL
$1.2 - $1.59 $840 - $1,113
-700 Reduced 2.89%
23,500 $34,000
Q3 2018

Nov 09, 2018

SELL
$1.38 - $2.27 $1 - $2
-1 Reduced -0.0%
24,200 $0
Q1 2018

May 15, 2018

SELL
$1.19 - $2.17 $1,531 - $2,792
-1,287 Reduced 5.05%
24,201 $44,000
Q4 2017

Feb 09, 2018

BUY
$0.98 - $2.27 $24,978 - $57,857
25,488
25,488 $29,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $41.7M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.